Evaluating the Feasibility of a Telescreening Program for Retinopathy of Prematurity (ROP) in Denmark

• Published in: Journal of personalized medicine 2024-09, Vol.14 (10), p.1020
• Main Authors: Al-Abaiji, Hajer A, Bangsgaard, Regitze, Kofod, Mads, Faber, Carsten, Larsen, Ann-Cathrine, Brost, Agnes Galbo, Slidsborg, Carina, Klemp, Kristian, Breindahl, Morten, la Cour, Morten Dornonville de, Kessel, Line
• Format: Article
• Language: English
• Subjects: Birth weight; Cameras; Children; Children & youth; Classification; Eye diseases; Feasibility studies; Gestational age; Local anesthesia; Medical personnel; Neonatal nursing; Onsite; Ophthalmology; Patient safety; Retinopathy; Retrolental fibroplasia; Telemedicine
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm14101020

: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. : National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO . The NPHP selected the best images for evaluation by an -site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent -site ophthalmologist. : A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the -site and -site ophthalmologists regarding ROP screening outcome was = 0.82, ROP stage = 0.69, plus disease = 0.69, and lastly ROP zone = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. : Telemedicine screening for ROP with the ICON GO camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.